DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Deleobuvir
Deleobuvir
Sofosbuvir
HCV Eradication with Direct Acting Antivirals (Daas)?
Caracterización Molecular Del Perfil De Resistencias Del Virus De La
IFNL4-ΔG Genotype Is Associated with Slower Viral Clearance In
Current Treatment of Chronic Hepatitis C
4 Activity Is Associated with Improved HCV Clearance and Reduced Expression of Interferon-Stimulated Genes
Interferon-Combination Strategies for the Treatment of Chronic Hepatitis C
Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection
Viekira + Rbv 1-1.2 12 96%
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
And Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: SOUND-C1 Final Results
HIV/HCV Coinfection
Contribution of Major Metabolites Towards Complex Drug-Drug Interactions of Deleobuvir: in Vitro Predictions and in Vivo Outcomes
206619Orig1s000
Optimization of an Interferon-Free Hepatitis C Virus Therapy Regimen
Naturally Occurring Resistance Mutations to Inhibitors of HCV
Appendix A: Online Search Strategies
Current Treatment of Chronic
Top View
Summary of Recently Published Studies on Treatments for Hepatitis C Working Document
Contribution of Major Metabolites Toward Complex Drug-Drug Interactions of Deleobuvir: in Vitro Predictions and in Vivo Outcomes S
An Open-Label, Phase Iib Study of Faldaprevir and Deleobuvir With
Chronic HCV: a Global Health Problem
Approved Antiviral Drugs Over the Past 50 Years
Annual Report 2013
PDF Download
Randomized, Open-Label, Prospective Pilot Study Group a (N = 14) Group
Rational Approach Toward COVID-19 Main Protease Inhibitors Via Molecular Docking, Molecular Dynamics Simulation and Free Energy
Sofosbuvir + Ribavirin in HCV G1
In USA Or HCV Genotype 1A /1B in Europe
Title of Presentation
Remdesivir from Wikipedia, the Free Encyclopedia
Notification of Discontinuation of a Paediatric Development Which Is Covered by an Agreed PIP Decision
Does the Choice of the Interferon Interfere with the SVR Response
Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir
209195Orig1s000
209394Orig1s000
Paritaprevir/Ombitasvir/Dasabuvir